JP2004536879A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004536879A5 JP2004536879A5 JP2003517002A JP2003517002A JP2004536879A5 JP 2004536879 A5 JP2004536879 A5 JP 2004536879A5 JP 2003517002 A JP2003517002 A JP 2003517002A JP 2003517002 A JP2003517002 A JP 2003517002A JP 2004536879 A5 JP2004536879 A5 JP 2004536879A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- formula
- alkyl
- disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT2001RM000464A ITRM20010464A1 (it) | 2001-07-31 | 2001-07-31 | Derivati retinoidi ad attivita' antiangiogenica, antitumorale e pro-apoptotica. |
| PCT/IT2002/000474 WO2003011808A1 (en) | 2001-07-31 | 2002-07-18 | Retinoid derivatives with antiangiogenic, antitumoral and proapoptotic activities |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004536879A JP2004536879A (ja) | 2004-12-09 |
| JP2004536879A5 true JP2004536879A5 (https=) | 2006-01-05 |
| JP4463550B2 JP4463550B2 (ja) | 2010-05-19 |
Family
ID=11455702
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2003517002A Expired - Fee Related JP4463550B2 (ja) | 2001-07-31 | 2002-07-18 | 抗血管新生、抗腫瘍性およびアポトーシス促進性の活性を有するレチノイド誘導体 |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US8101793B2 (https=) |
| EP (1) | EP1412317B1 (https=) |
| JP (1) | JP4463550B2 (https=) |
| KR (1) | KR100888466B1 (https=) |
| CN (1) | CN1279014C (https=) |
| AT (1) | ATE492526T1 (https=) |
| AU (1) | AU2002326144B2 (https=) |
| BR (1) | BR0211521A (https=) |
| CA (1) | CA2454532C (https=) |
| CY (1) | CY1114535T1 (https=) |
| DE (1) | DE60238683D1 (https=) |
| DK (1) | DK1412317T3 (https=) |
| ES (1) | ES2358097T3 (https=) |
| HU (1) | HU229308B1 (https=) |
| IT (1) | ITRM20010464A1 (https=) |
| MX (1) | MXPA04000877A (https=) |
| PL (1) | PL207530B1 (https=) |
| PT (1) | PT1412317E (https=) |
| WO (1) | WO2003011808A1 (https=) |
Families Citing this family (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060062786A1 (en) * | 2000-11-08 | 2006-03-23 | Human Genome Sciences, Inc. | Antibodies that immunospecifically bind to TRAIL receptors |
| US20030228309A1 (en) * | 2000-11-08 | 2003-12-11 | Theodora Salcedo | Antibodies that immunospecifically bind to TRAIL receptors |
| US20050214209A1 (en) * | 2001-05-25 | 2005-09-29 | Human Genome Sciences, Inc. | Antibodies that immunospecifically bind to TRAIL receptors |
| US20050129616A1 (en) * | 2001-05-25 | 2005-06-16 | Human Genome Sciences, Inc. | Antibodies that immunospecifically bind to TRAIL receptors |
| US7348003B2 (en) | 2001-05-25 | 2008-03-25 | Human Genome Sciences, Inc. | Methods of treating cancer using antibodies that immunospecifically bind to TRAIL receptors |
| US7361341B2 (en) * | 2001-05-25 | 2008-04-22 | Human Genome Sciences, Inc. | Methods of treating cancer using antibodies that immunospecifically bind to trail receptors |
| US20090226429A1 (en) * | 2001-05-25 | 2009-09-10 | Human Genome Sciences, Inc. | Antibodies That Immunospecifically Bind to TRAIL Receptors |
| ITRM20010464A1 (it) * | 2001-07-31 | 2003-01-31 | Sigma Tau Ind Farmaceuti | Derivati retinoidi ad attivita' antiangiogenica, antitumorale e pro-apoptotica. |
| EP1456165A1 (en) * | 2001-11-30 | 2004-09-15 | The Burnham Institute | Induction of apoptosis in cancer cells |
| CA2471140A1 (en) * | 2001-12-20 | 2003-07-03 | Human Genome Sciences, Inc. | Antibodies that immunospecifically bind to trail receptors |
| CA2598518C (en) | 2005-02-22 | 2015-04-21 | Ranbaxy Laboratories Limited | 5-phenyl-pentanoic acid derivatives as matrix metalloproteinase inhibitors for the treatment of asthma and other diseases |
| FR2884248B1 (fr) * | 2005-04-08 | 2007-05-18 | Galderma Res & Dev | Nouveau procede de preparation de l'acide 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphtoique |
| JP5155148B2 (ja) * | 2005-04-08 | 2013-02-27 | ガルデルマ・リサーチ・アンド・デヴェロップメント | ６−［３−（１−アダマンチル）−４−メトキシフェニル］−２−ナフトエ酸の合成方法 |
| ITRM20050248A1 (it) * | 2005-05-20 | 2006-11-21 | Sigma Tau Ind Farmaceuti | Uso acido adamantil metossidifenil propenoico per il trattamento di patologie cutanee. |
| JP5080462B2 (ja) | 2005-06-28 | 2012-11-21 | シグマ−タウ・インドゥストリエ・ファルマチェウチケ・リウニテ・ソシエタ・ペル・アチオニ | ビフェニルおよびナフチル−フェニルヒドロキサム酸誘導体 |
| WO2007037188A1 (ja) * | 2005-09-27 | 2007-04-05 | Sapporo Medical University | 血管透過性亢進に起因する眼疾患の予防及び治療のための医薬 |
| WO2007071605A1 (en) * | 2005-12-19 | 2007-06-28 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | The use of st1898 for the treatment of restenosis |
| JP5054006B2 (ja) * | 2006-06-23 | 2012-10-24 | ロート製薬株式会社 | ヒアルロン酸産生促進能を有する組成物 |
| US20100330200A1 (en) * | 2006-12-22 | 2010-12-30 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Combination of a retinoid and a platinum anticancer agent |
| WO2010000784A1 (en) * | 2008-07-03 | 2010-01-07 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Treatment of restenosis |
| TW201031402A (en) * | 2008-12-24 | 2010-09-01 | Sigma Tau Ind Farmaceuti | New retinoid derivatives endowed with cytotoxic and/or antiangiogenic properties |
| WO2010096264A2 (en) | 2009-02-03 | 2010-08-26 | Children's Medical Center Corporation | Methods for enhancing hematopoietic stem/progenitor cell engraftment |
| WO2010091052A2 (en) | 2009-02-03 | 2010-08-12 | Children's Medical Center Corporation | Methods for enhancing hematopoietic stem/progenitor cell engraftment |
| WO2010106135A1 (en) | 2009-03-20 | 2010-09-23 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Combined use for the treatment of ovarian carcinoma |
| CN102892755A (zh) | 2009-12-23 | 2013-01-23 | 韦恩州立大学 | 治疗性化合物 |
| AU2012311640B2 (en) * | 2011-09-19 | 2017-04-13 | Alfasigma S.P.A. | New thio derivatives bearing lactams as potent HDAC inhibitors and their uses as medicaments |
| JP5757602B2 (ja) * | 2012-05-11 | 2015-07-29 | 国立大学法人金沢大学 | 不斉選択性の切り替えが可能なクロマトグラフィー用充填剤 |
| CN104496839B (zh) * | 2014-12-03 | 2016-04-20 | 广东东阳光药业有限公司 | 取代环丁烷类神经氨酸酶抑制剂及其使用方法和用途 |
| WO2017053778A1 (en) | 2015-09-25 | 2017-03-30 | Fuchs Helen Burgwyn | Antibacterial and antifungal compounds |
| AU2017208970A1 (en) | 2016-01-18 | 2018-08-02 | Arisan Therapeutics | Adamatane derivatives for the treatment of filovirus infection |
| EP3301085A1 (en) * | 2016-09-29 | 2018-04-04 | Biogem S.Ca.R.L. | Retinoid derivatives with antitumor activity |
| WO2018201074A1 (en) * | 2017-04-27 | 2018-11-01 | Vanderbilt University | Methods for treating atherosclerosis with gamma-ketoaldehyde scavengers |
| US11278025B2 (en) | 2017-05-17 | 2022-03-22 | The General Hospital Corporation | Antibiotic compounds |
| WO2019018185A1 (en) | 2017-07-15 | 2019-01-24 | Arisan Therapeutics Inc. | ENANTIOMERICALLY PURE ADAMATANE DERIVATIVES FOR THE TREATMENT OF FILOVIRUS INFECTIONS |
| IT201900003343A1 (it) * | 2019-03-07 | 2020-09-07 | Special Product’S Line S P A | Derivati fenolici per uso come antimicrobici, antibatterici, battericidi |
| CN111956806B (zh) * | 2020-09-03 | 2023-04-07 | 四川大学 | 一种药物载体、胶束、药剂及其制备方法和应用 |
| IT202000029882A1 (it) * | 2020-12-04 | 2022-06-04 | Special Product’S Line S P A | Derivati fenolici per uso come antimicrobici, antibatterici, battericidi |
| IT202000029906A1 (it) * | 2020-12-04 | 2022-06-04 | Special Product’S Line S P A | Derivati fenolici per uso come antimicrobici, antibatterici, battericidi. |
| WO2022229017A1 (en) | 2021-04-27 | 2022-11-03 | Biogem S.C.A R.L. | Adamantyl retinoid derivative with anticancer activity |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2676052B1 (fr) * | 1991-05-02 | 1994-04-29 | Cird Galderma | Nouveaux composes polycycliques aromatiques et leur utilisation en medecine humaine ou veterinaire et en cosmetique. |
| IL127946A0 (en) * | 1996-07-08 | 2000-02-17 | Cird Galderma | Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents |
| ITRM20010464A1 (it) * | 2001-07-31 | 2003-01-31 | Sigma Tau Ind Farmaceuti | Derivati retinoidi ad attivita' antiangiogenica, antitumorale e pro-apoptotica. |
| EP1456165A1 (en) * | 2001-11-30 | 2004-09-15 | The Burnham Institute | Induction of apoptosis in cancer cells |
-
2001
- 2001-07-31 IT IT2001RM000464A patent/ITRM20010464A1/it unknown
-
2002
- 2002-07-18 ES ES02760553T patent/ES2358097T3/es not_active Expired - Lifetime
- 2002-07-18 WO PCT/IT2002/000474 patent/WO2003011808A1/en not_active Ceased
- 2002-07-18 US US10/485,530 patent/US8101793B2/en not_active Expired - Fee Related
- 2002-07-18 AU AU2002326144A patent/AU2002326144B2/en not_active Ceased
- 2002-07-18 KR KR1020047001546A patent/KR100888466B1/ko not_active Expired - Fee Related
- 2002-07-18 BR BR0211521-2A patent/BR0211521A/pt not_active IP Right Cessation
- 2002-07-18 CN CNB028150082A patent/CN1279014C/zh not_active Expired - Fee Related
- 2002-07-18 CA CA2454532A patent/CA2454532C/en not_active Expired - Fee Related
- 2002-07-18 HU HU0401604A patent/HU229308B1/hu not_active IP Right Cessation
- 2002-07-18 JP JP2003517002A patent/JP4463550B2/ja not_active Expired - Fee Related
- 2002-07-18 PL PL368412A patent/PL207530B1/pl not_active IP Right Cessation
- 2002-07-18 PT PT02760553T patent/PT1412317E/pt unknown
- 2002-07-18 MX MXPA04000877A patent/MXPA04000877A/es active IP Right Grant
- 2002-07-18 AT AT02760553T patent/ATE492526T1/de active
- 2002-07-18 EP EP02760553A patent/EP1412317B1/en not_active Expired - Lifetime
- 2002-07-18 DK DK02760553.4T patent/DK1412317T3/da active
- 2002-07-18 DE DE60238683T patent/DE60238683D1/de not_active Expired - Lifetime
-
2007
- 2007-06-20 US US11/765,737 patent/US7449495B2/en not_active Expired - Fee Related
-
2011
- 2011-03-16 CY CY20111100294T patent/CY1114535T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004536879A5 (https=) | ||
| CA2454532A1 (en) | Retinoid derivatives with antiangiogenic, antitumoral and proapoptotic activities | |
| EP1104297B1 (en) | Compositions for the treatment of chronic lymphocytic leukemia | |
| JP6005855B2 (ja) | 血管破壊薬および低酸素を標的とする薬剤を含む併用療法 | |
| JP2006523216A5 (https=) | ||
| RU2005107314A (ru) | Пиримидопроизводные, характеризующиеся антипролиферативной активностью | |
| JP2015163628A (ja) | 腫瘍転移および癌の治療 | |
| CN100344611C (zh) | 4－硝基－2－[(4′－甲氧基)－苯氧基]－甲磺酰苯胺衍生物及其医药用途 | |
| JP2006503850A5 (https=) | ||
| JP2004529114A5 (https=) | ||
| JP2006515004A5 (https=) | ||
| CN1283248C (zh) | 包含埃坡霉素的组合及其药学应用 | |
| AU2008236994A1 (en) | Method of treating melanoma | |
| JP2005532269A5 (https=) | ||
| JP2005527575A5 (https=) | ||
| CN1750825A (zh) | 黄酮乙酸类似物以及其使用方法 | |
| JP2009541473A (ja) | 治療剤におけるイミダゾ［１，２−ａ］ピリジン−２−カルボキサミド誘導体の使用 | |
| RU2016110546A (ru) | Комбинированная лекарственная терапия | |
| CN1299348A (zh) | 用于治疗疾病的sPLA2抑制剂化合物 | |
| JP2010500971A5 (https=) | ||
| JP2004528311A5 (https=) | ||
| JP2007514732A5 (https=) | ||
| CN1305997A (zh) | 双氯芬酸偶联衍生物、其合成方法及抗炎作用 | |
| JP2003535874A (ja) | 置換アクリロイルジスタマイシン誘導体、タキサン類及び／又は代謝拮抗剤を含む腫瘍に対する併用療法 | |
| JP2019196361A (ja) | 置換フェニル−（１，３−ジヒドロ−イソインドール−２−イル）−メタノンを含んでなる医薬処方物 |